Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by bealerton Dec 08, 2022 1:37pm
180 Views
Post# 35159680

Positive News Release

Positive News ReleaseThe news has been released just in time to avoid tax loss selling, but some will sell anyway.

There are only two things that I believe about Sirona: They know just the right time to dangle the carrot again to retain investor interest after 13 odd years to perfect this art. The second thing I believe is they don't even know how inept they are at running a company and are too proud and stubborn to admit that someone else might do a better job. Yes, they know how to do financials and governance, etc. but are not able to negotiate any solid deals that will bring some REAL MONEY to the table.  Always a down the road thing and the share price tells the whole story.

I will give credit for the new test underway and all that good stuff, but I stick to my conviction that the shareholders have been given little respect over the years, the very people that provide their exorbitant paychecks.

Sirona, where is your 2023 budget for shareholders to examine?

BeAlert, and hope for the best.
Merry Christmas to all who read this, and a prosperous New Year.
<< Previous
Bullboard Posts
Next >>